google-site-verification=4pMzCV_MSfjBxsqgSEQrFmQ4q_Zv5vDBjNsaTIaNpc4
top of page

 The Government’s Hidden Cannabis Patent's, Rick Simpson Oil & the War on Natural Medicine

​👮 Age Verification Exploit & Content Disclaimer | UPDATED PUBLIC SECURITY NOTICE

​

​Big Pharma’s Hypocrisy's — The Patent's, & Suppressed Plant Medicine​'s

​

​​​In 2003, the U.S. Department of Health and Human Services secured (Patent US6630507B1), officially recognizing cannabinoids as “antioxidants and neuroprotectants” — beneficial in treating: 

​​​

Yet under federal law, cannabis remains a Schedule I drug, officially declared as having “no accepted medical use.” This contradiction exposes a policy-driven system prioritizing profits over people — protecting a $50 billion opioid and antidepressant industry.

​​

🌿 The Endocannabinoid System: God’s Thermostat

The endocannabinoid system (ECS), — discovered in the 1990s — is your body’s God-designed biological regulator, balancing:

​​

​The following sections summarize peer-reviewed research and documented case observations and are not presented as medical advice.

​

Cannabinoids from cannabis—THC, CBD, CBG—mimic the body’s natural endocannabinoids, restoring balance (homeostasis) in chronic conditions.

Supporting research:

​

Big Pharma masks symptoms. Cannabis addresses causes.

​

🩺 Rick Simpson Oil: A Suppressed Natural Remedy

In 2003, Canadian engineer Rick Simpson reported recovery from skin cancer after using a high-THC, full-spectrum cannabis oil inspired by National Cancer Institute research. Known as Rick Simpson Oil (RSO), it’s reportedly helped thousands with:​

Suppression evidence:

​

But instead of recognition, Rick faced raids, arrests, and charges for distributing medicine freely. Harassed out of Canada, he relocated to Uruguay, the first modern nation to legalize cannabis (2013, under President José Mujica).

Meanwhile, U.S. Patent 6630507B1 downplayed THC and prioritized CBD — paving the way for Big Pharma’s patented drugs like Epidiolex, while sidelining natural cures like RSO.

​

🔍 Clarification on Language, Evidence & Historical Comparison

(Editorial & Legal Context)

The statements and examples presented in this document are grounded in publicly available research, government records, historical rulings, and documented personal experiences. They are not intended to function as medical prescriptions or universal medical claims.

​

When personal recovery experiences are discussed—including those of Rick Simpson and my own—they are presented as reported outcomes and lived testimony, not as guarantees, diagnoses, or medical advice. Individual results vary, and all medical decisions should involve qualified professionals.

​

Similarly, references to historical suppression programs such as COINTELPRO are used as contextual and structural comparisons. The comparison is intended to highlight recognizable patterns—such as censorship, intimidation, and disruption of lawful advocacy—documented both historically and in modern public records.

​

This document invites examination, not blind acceptance. All readers are encouraged to review the cited patents, studies, court rulings, and historical records directly.

​

In 2003, patent No. 6630507b1 was granted to the Department of Health and Human Services. "Cannabinoids have been found to have antioxidant properties." Patent No. 6630507b1 also references 24 other U.S. patents related to cannabis dating back to 1942. U.S. Patent No. 6630507b1 covers the potential use of non-psychoactive cannabinoids to protect the brain from damage or degeneration caused by certain diseases.

​

📚 The Government Knew All Along

​

🧪 Government & Big Pharma Cannabis-Derived Medications (1942–Present)

Despite public claims that cannabis has “no accepted medical use,” at least two dozen cannabinoid-related drugs, isolates, or synthetic analogs have been researched, patented, or commercialized by governments and pharmaceutical corporations since 1942. These products extract, mimic, or isolate compounds found naturally in the cannabis plant — while the whole plant itself remained prohibited.

​

🔹 Early Government & Military Research (1940s–1970s)

  1. Cannabinol (CBN) — studied by U.S. Army and NIH researchers for sedation and pain relief

  2. Δ9-THC (isolated) — synthesized and studied following WWII pharmacological programs

  3. Δ8-THC — government-researched isomer, later commercialized

  4. Nabilone (early synthesis) — cannabinoid analogs explored for nausea

  5. Levonantradol — U.S. Army–funded synthetic cannabinoid for pain (1970s)

 

These compounds were researched while cannabis was simultaneously criminalized.

 

🔹 FDA-Approved Synthetic & Isolated Cannabinoids (U.S.)

  1. Marinol (Dronabinol) — synthetic THC (1985)

  2. Syndros (Dronabinol oral solution) — synthetic THC

  3. Cesamet (Nabilone) — synthetic THC analog

  4. Epidiolex (Cannabidiol) — purified plant-derived CBD

​

⚠️ None of these are whole-plant medicines.​

🔹 Internationally Approved or Government-Backed Cannabinoid Medicines

  1. Sativex (Nabiximols) — THC:CBD botanical extract (UK, EU, Canada)

  2. Bedrocan Medical Cannabis — standardized government-regulated cannabis (Netherlands)

  3. Bediol — THC/CBD pharmaceutical cultivar

  4. Tilray Oral Solutions — government-approved medical cannabis extracts

  5. Cannador — standardized THC/CBD capsule (Germany)

 

🔹 Investigational / Suppressed / Abandoned Cannabinoid Drugs

  1. Dexanabinol (HU-211) — neuroprotectant studied for stroke & TBI

  2. Rimonabant — CB1 antagonist (withdrawn despite metabolic benefits)

  3. Ajulemic Acid (CT-3) — synthetic THC metabolite (anti-inflammatory)

  4. O-1602 — cannabinoid-like compound targeting inflammation

  5. JWH-018 (research compound) — basis for later “synthetic cannabinoids”

  6. HU-210 — potent synthetic cannabinoid (Israeli gov’t research)

 

🔹 Modern Pharma & Government Cannabinoid Programs

  1. GW Pharmaceuticals cannabinoid isolates (pre-acquisition by Jazz Pharma)

  2. NIH-funded CBD analogs for addiction & anxiety

  3. DEA-registered cannabinoid research compounds

  4. CBG/CBC pharmaceutical isolates currently in development pipelines

 

📌 The Contradiction Exposed

 

📑 Updated Patent Record Clarification (Expanded Federal Acknowledgment)

While U.S. Patent No. 6630507B1 references 24 earlier cannabis-related patents dating back to 1942, the broader federal patent record shows far more extensive activity.

​

The United States Patent and Trademark Office has issued hundreds of cannabis-related patents over the past several decades, with thousands of related applications filed. These patents cover:

• Cannabinoid compositions (THC, CBD, CBG, CBC & analogs)
• Neuroprotective & antioxidant applications (Expanded)
• Anti-inflammatory formulations
• Synthetic cannabinoid analogs
• Extraction & purification methods
• Drug delivery systems
• Cannabis plant genetics & cultivars
• Pharmaceutical cannabinoid isolates

 

Federal agencies themselves have held or funded cannabinoid patents, including the 2003 patent granted to the U.S. Department of Health and Human Services recognizing cannabinoids as antioxidants and neuroprotectants.

This demonstrates a long-standing scientific acknowledgment of cannabinoid pharmacology — even during decades in which cannabis remained classified under Schedule I of the Controlled Substances Act as having “no accepted medical use.”

​

The contradiction is therefore not limited to a single patent, but reflects a broader pattern of:

• Ongoing federal cannabinoid research
• Government-recognized therapeutic potential

• Commercial pharmaceutical development
• Continued prohibition of the whole plant

​

Although Patent 6630507B1 references 24 earlier patents, the full record from the U.S. Patent and Trademark Office reveals hundreds of cannabis-related patents and thousands of applications covering cannabinoid medicine, formulations, and delivery systems. Federal agencies have long recognized cannabinoid pharmacology — even while the cannabis plant itself remained Schedule I under the Controlled Substances Act.

​

While many cannabinoid-based drugs have been produced, patented, or approved, the cannabis plant itself remains federally restricted.

 

This contradiction directly conflicts with U.S. Patent 6630507B1, which acknowledges cannabinoids as neuroprotective antioxidants useful in Alzheimer’s, Parkinson’s, stroke, and neurodegenerative disease.

​

This is not a failure of science; it is a controlled funneling of medicine into patentable form.

 

🕵️‍♂️ COINTELPRO 2.0: Modern Suppression of Healing Truth

Between 1956–1971, COINTELPRO was used to infiltrate and silence voices of truth—through surveillance, disinformation, harassment, and sabotage.

 

Today, we see the same blueprint applied to medical freedom and cannabis advocacy:

 

Just as COINTELPRO destroyed civil rights and activist leaders, COINTELPRO 2.0 now targets natural medicine advocates.

 

🚫 False Alternatives: Delta-8 & Synthetic Cannabinoids

While natural, God-made cannabis remains restricted, synthetic derivatives are promoted:

 

These distractions keep the public from the true, whole-plant medicine God designed while simultaneously classifying it as Schedule I (no accepted medical use) under the Controlled Substances Act.

​

✝️ My Personal Living Testimony

This isn’t just theory — it’s personal. https://poe.com/s/D0qUuTTnWzSHsakZ7HEh

I am living proof of the healing power that US6630507B1 describes. Through God’s grace and the natural medicine He provided in creation, I found recovery when pharmaceuticals failed. The very neuroprotective and restorative properties acknowledged in this patent played a role in my healing journey. 

​

The patent proves the truth of what many patients, caregivers, and natural medicine advocates have been saying for decades: cannabis is not a drug of destruction — it is a medicine of restoration.​

 

📜 Biblical Foundation

  • Psalm 104:14 — “He causeth the grass to grow for the cattle, and herb for the service of man.”

  • Genesis 1:29 — “Every herb bearing seed… to you it shall be for meat.”

  • Luke 8:17 — “For nothing is secret, that shall not be made manifest.”

​​

Plant-based cannabinoids, notably CBD and low-dose THC, have been documented in medical literature and clinical trials to provide significant neuroprotective and restorative effects in conditions such as Alzheimer’s disease and addiction recovery, in alignment with established scientific and governmental findings.

​

Alzheimer’s Disease & Cannabinoid Treatment

Research shows that cannabinoids can help reduce agitation, aggression, and cognitive impairments in Alzheimer’s and dementia patients, with case studies and clinical trials demonstrating symptom improvement and even deprescription of other medications. Cannabinoids have been proven to act as neuroprotectants, limiting neurodegenerative damage by reducing oxidative stress and neuroinflammation—mechanisms central to Alzheimer’s pathology.

  • Multiple studies and clinical observations have shown improvements in cognitive and behavioral symptoms after cannabinoid treatment, some lasting several months or longer.

  • The U.S. patent US6630507B1 specifically affirms cannabinoids’ role as potent neuroprotectants with application in neurodegenerative diseases like Alzheimer’s.

  • Ongoing clinical trials continue to assess the safety, efficacy, and optimal dosing strategies of cannabinoids in Alzheimer’s patients.

 

Addiction Recovery Using Cannabinoids

CBD has demonstrated substantial, sustained benefits in aiding recovery from substance dependencies, including opioid, cocaine, tobacco, and alcohol addictions.

  • Studies show CBD targets relapse triggers such as anxiety, impaired impulse control, and environmental cues, producing long-lasting reductions in drug-seeking behavior and relapse vulnerability.

  • Evidence supports CBD’s efficacy across multiple substance classes, with results suggesting broader therapeutic utility beyond single-drug addiction.

  • Medical reports detail documented recovery cases, highlighting CBD as a non-addictive, non-psychoactive option for sustained freedom from addiction.

 

Biblical Perspective: Truth & God’s Creation

Scripturally, God's creation provides natural resources for healing and restoration, often obscured by human systems that may suppress alternative approaches. The documented effectiveness of cannabinoids supports the concept of divine provision embedded in creation, aligning with themes of healing, restoration, and revelation of hidden truths referenced in end-time prophecy.

  • Clinical and governmental acknowledgment of cannabinoids’ healing properties affirms the notion that God’s natural creation holds valuable solutions for human disease and suffering.

 

U.S. Government Patent Confirmation

U.S. Patent US6630507B1, held by the U.S. government, clearly recognizes cannabinoids as powerful antioxidants and neuroprotectants, beneficial for “limiting damage from oxidative stress and neurodegenerative diseases,” with non-psychoactive cannabinoids preferred for their safety and effectiveness.

​

In summary, verified medical recoveries from Alzheimer’s disease and addiction through plant-based cannabinoid therapy are documented, providing real-world affirmation of both biblical and scientific truth regarding God’s healing creation.​​

​​

This is not incompetence. It is policy-driven suppression for profit. (Disclaimer & Scope of Use)​

​​

(Keneh-Bosem Pages) THE LOST CANNABIS OF SCRIPTURE​

 

​Medical Cannabis Patient Access and Education Act 

​​

​"For nothing is secret, that shall not be made manifest; neither any thing hid, that shall not be known and come abroad." — Luke 8:17

___________________________________________________________________________________________________

​

**KANEH-BOSEM: THE LOST CANNABIS OF SCRIPTURE — A RESTORED STUDY**  
*A Comprehensive Linguistic, Archaeological, Historical, and Theological Examination of Cannabis in the Biblical World*

​

### Core Thesis

The Hebrew phrase **שֶׂמֶבֹּנה־ֶקָ** (*kaneh-bosem*), often translated as “calamus,” “sweet cane,” or “aromatic reed,” most likely refers to **cannabis** in multiple biblical passages. This study synthesizes linguistic evidence, ancient trade and usage patterns, comparative Semitic terminology, archaeological discoveries (notably at Tel Arad), ritual practices, medicinal history, and theological symbolism. The goal is to demonstrate that cannabis was known in the ancient Near East and held ceremonial, medicinal, economic, and symbolic significance among surrounding cultures—including ancient Israel. While absolute certainty may be elusive, the cumulative evidence warrants serious scholarly reconsideration rather than dismissal based on traditional assumptions.

​

### PART 1: THE LINGUISTIC FOUNDATION OF KANEH-BOSEM

#### 1.1 The Hebrew Term

The phrase **kaneh-bosem** is a compound of two elements:

- **Qaneh (נהֶקָ):** means reed, stalk, cane, or measuring rod—implying a tall, upright, hollow or fibrous stem.  
- **Bosem (שםֶׂבֹּ):** means fragrant, aromatic spice, or perfume.

**Combined meaning:** “aromatic reed” or “fragrant cane.”  
This term appears in:  
- Exodus 30:23  
- Song of Solomon 4:14  
- Isaiah 43:24  
- Ezekiel 27:19  
- Jeremiah 6:6

#### 1.2 The Septuagint Translation Problem

When the Hebrew Scriptures were translated into Greek (the Septuagint, 3rd–2nd century BCE), **qaneh** was rendered as **κάλαμος** (*kalamos*)—a broad Greek term for reed, cane, stalk, or measuring rod. This was a general term, not a botanical identification. Over time, later interpreters associated **calamus** with **Acorus calamus** (sweet flag). Importantly, no primary Hebrew text explicitly identifies **kaneh-bosem** as **Acorus calamus**; this identification emerged as a post-biblical inference.

#### 1.3 Sula Benet and the Cannabis Etymology

Anthropologist **Sula Benet** (Sara Benetowa) in the 20th century proposed a linguistic chain linking **kaneh-bosem** to ancient cannabis-related terms:

*Hebrew* **qaneh** → *Assyrian* **qunnabu** → *Akkadian* **qunnapu** → *Scythian/Thracian* forms → *Greek* **kannabis** → *Latin* **cannabis**.

Ancient Assyrian records describe **qunnabu** as a source of oil, fiber, incense, and medicine—uses that align with the documented applications of cannabis. This comparative philology, reinforced by material culture, suggests a strong link between **kaneh-bosem** and **cannabis**.

#### 1.4 Qaneh as a Measuring Rod

Scriptural references to **qaneh** often depict it as a tall, straight measuring rod (e.g., Ezekiel 40:3–5; Revelation 11:1). Such imagery implies a tall, sturdy plant.  
- *Cannabis sativa* can reach 10–20 feet, with fibrous, rigid stalks suitable for rods, rope, and construction.  
- *Acorus calamus* usually grows only 2–5 feet with a soft, fleshy rhizome, unsuitable as a measuring rod.  
This practical mismatch questions the identification of **kaneh-bosem** as calamus.

​

### PART 2: EXODUS 30’S HOLY ANOINTING OIL — TOXICOLOGICAL & THEOLOGICAL REASSESSMENT

#### 2.1 The Sacred Formula

Exodus 30:22–25 lists ingredients for the sacred anointing oil:

- Myrrh  
- Cinnamon  
- **Kaneh-bosem**  
- Cassia  
- Olive oil

This oil was used to consecrate priests, kings, prophets, and tabernacle furnishings.

#### 2.2 Why Calamus Cannot Be the Intended Ingredient

The argument: **God did not command the inclusion of calamus** (Acorus calamus) in the anointing oil.  
- Many calamus chemotypes contain **β-asarone**, a compound shown to be genotoxic and carcinogenic in animal studies—linked to liver tumors and DNA damage.  
- Using a known carcinogen in sacred rituals is incompatible with the character of a Holy Lawgiver.  
- **Cannabis**, by contrast, lacks such genotoxic compounds and has historically been used in medicinal and aromatic preparations, fitting the ritual context.

#### 2.3 Ancient Oil Extraction Compatibility

Cannabinoids are fat-soluble. Gentle heating in olive oil could extract medicinal and aromatic compounds, consistent with ancient perfumery and medicinal practices.  
This supports the idea that cannabis-infused oils could serve both ritual and therapeutic purposes.

​

### PART 3: ARCHAEOLOGICAL EVIDENCE — TEL ARAD & RITUAL CANNABIS

#### 3.1 The Discovery

In 2020, chemical analyses of residues from the Judahite shrine at **Tel Arad** revealed traces of **THC**, **CBD**, and **CBN**—the clearest direct archaeological evidence of cannabis in an Israelite ritual context.

#### 3.2 The Shrine Context

The altar was associated with incense burning and temple-style worship. Researchers suggest that cannabis was likely mixed with animal dung or fat to enable low-temperature smoldering, indicating intentional ceremonial use. This raises the question: **Was “kaneh-bosem” the name of this plant?**

​

### PART 4: THE GLOBAL CONTEXT OF SACRED CANNABIS

Ancient societies surrounding Israel used cannabis ceremonially and medicinally:

- **Scythians** (Herodotus, *Histories* 4.75): inhaled hemp vapors in ritual tents.  
- **India**: used in religious rituals, associated with Shiva.  
- **China**: documented for pain relief, surgery, and medicinal use.  
- **Pamir Mountains** (~500 BCE): braziers with THC residues suggest ritual fumigation.

Shared trade routes and cultural exchanges make it plausible that cannabis was known and used across these regions.

​

### PART 5: CALAMUS VS. CANNABIS — COMPARATIVE OVERVIEW

| Feature | *Acorus calamus* (Sweet Flag) | *Cannabis sativa/indica* |
|---------|------------------------------|-------------------------|
| Aromatic | Yes (weak) | Yes (strong, terpene-rich) |
| Height | 2–5 ft, soft rhizome | 10–20 ft, fibrous, rigid stalks |
| Measuring rod suitability | No | Yes |
| Oil infusion compatibility | Poor (water-soluble rhizome) | Excellent (fat-soluble) |
| Incense use | Limited | Extensive (worldwide tradition) |
| Evidence in Judah | Minimal | Supported by Tel Arad + trade links |
| Toxicity | Contains β-asarone (carcinogenic) | No known similar toxicity |
| Ritual use nearby | No | Yes (Scythia, India, China) |

---

### PART 6: EZEKIEL’S MEASURING REED & SYMBOLIC CONNECTION

Ezekiel 40:5 describes a heavenly messenger measuring the Temple with a **qaneh** of six cubits (~9–11 feet).  
- The study suggests this indicates a tall, cane-like plant—consistent with **cannabis hemp**.  
- Calamus, being much shorter, cannot fit this imagery.  
- This reinforces the semantic range of **qaneh** as a tall reed.

 

### PART 7: THEOLOGICAL CONCLUSION — A BALANCED POSITION

This study emphasizes avoiding two errors:

- **Overclaiming spiritual power:** Cannabis does not inherently provide enlightenment or holiness. Salvation is through faith in Christ alone.  
- **Labeling every medicinal or plant-based substance as evil:** Scripture affirms creation as “very good” (Genesis 1:31). Plants are given for medicine (e.g., Ezekiel 47:12) and ritual use.

**Our affirmations:**

- The biblical **calamus** identification as *Acorus calamus* is likely a mistranslation, amplified by the Septuagint’s broad **kalamos** and later tradition.  
- The linguistic, archaeological, botanical, and toxicological evidence points toward **cannabis** as the plant behind **kaneh-bosem**.  
- Cannabis, like all creation, can be used wisely for medicine, ritual, and fiber, or abused. Scripture condemns drunkenness, not responsible plant stewardship.  
- Central to Christian faith are Christ, repentance, wisdom, stewardship, and truth—not any particular plant. Correcting mistranslations honors God’s character.

​

​

### FINAL SUMMARY

The convergence of evidence from:

- Semitic linguistics (Benet’s *qunnabu* chain)  
- Archaeological findings (Tel Arad THC/CBD residues)  
- Theological considerations (toxicity of calamus)  
- Botanical practicality (height and oil infusion potential)  
- Ancient ritual parallels (Scythia, India, China)  
- Biblical symbolism (measuring reed, anointing oil, themes of restoration)  

…builds a compelling case that **kaneh-bosem** is best understood as **cannabis**, not calamus.

​

**In conclusion**, the traditional translation of *calamus* is a historical error that should be reconsidered. The “lost cannabis of Scripture” is a correction rooted in linguistic, archaeological, and botanical evidence—aiming to honor biblical accuracy and God’s good creation.

​

> “Prove all things; hold fast that which is good.” — **1 Thessalonians 5:21**

Directory - "Smoking Flax" - Keneh-Bosem - Calamus vs Cannabis - Measuring Reed - Hyssop - Sweet Cane

bottom of page